2005
Characterization of a likelihood based method and effects of markers informativeness in evaluation of admixture and population group assignment
Yang BZ, Zhao H, Kranzler HR, Gelernter J. Characterization of a likelihood based method and effects of markers informativeness in evaluation of admixture and population group assignment. BMC Genomic Data 2005, 6: 50. PMID: 16225681, PMCID: PMC1285360, DOI: 10.1186/1471-2156-6-50.Peer-Reviewed Original Research
1994
Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine
Rao PA, Pickar D, Gejman PV, Ram A, Gershon ES, Gelernter J. Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine. JAMA Psychiatry 1994, 51: 912-917. PMID: 7944879, DOI: 10.1001/archpsyc.1994.03950110072009.Peer-Reviewed Original ResearchConceptsClinical responseTherapeutic effectAtypical antipsychotic drug clozapineClozapine's therapeutic effectsTreatment-refractory schizophreniaPathophysiology of schizophreniaAntipsychotic drug clozapineD4 dopamine receptorsDRD4 allelesPutative third cytoplasmic loopSchizoaffective patientsTherapeutic responseTherapy variesDopamine receptorsSchizoaffective subjectsTreatment responseThird cytoplasmic loopDrug clozapineClozapineDopamine receptor geneSchizoaffective disorderD4 receptorsPolymerase chain reaction amplificationReceptor allelesChain reaction amplification
1989
Detection of marker associations with a dominant disease gene in genetically complex and heterogeneous diseases.
Gershon ES, Martinez M, Goldin L, Gelernter J, Silver J. Detection of marker associations with a dominant disease gene in genetically complex and heterogeneous diseases. American Journal Of Human Genetics 1989, 45: 578-85. PMID: 2491015, PMCID: PMC1683506.Peer-Reviewed Original Research